Tag Archive | "Influenza"

CSL has acquired the Flu vaccine business from Novartis

Tags: , , ,


Novartis announced has entered an agreement that CSL has acquired its influenza vaccine business in a $275 million deal that will require regulatory approval before it closes by the end of the second half of 2015. Read the full story

CSL: Partnering activity 2005-2013

Tags: , , ,


CSL is a global pharma company active in the development of vaccines and plasma proteins with a prime focus on influenza vaccine - partnering, collaborative R&D and licensing activity of CSL is reviewed here.

Read the full story

Vivaldi Biosciences biotech partners with Baxter for influenza vaccine assets

Tags: , , , ,


Vivaldi Biosciences has acquired from Baxter Healthcare research and development assets, including intellectual property, clinical data, know-how and materials, for LAIVs in which the gene for influenza nonstructural protein 1 has been fully deleted Read the full story

CureVac in pharma licensing deal with Janssen for influenza vaccine

Tags: , , , ,


CureVac has entered into a collaboration and pharma licensing agreement with Janssen Pharmaceuticals Read the full story

CSL Biotherapies makes pharma news with $1.5 billion award from US Government

Tags: , , ,


A popular headlines on the pharma news was CSL Biotherapies award of $1.5billion from the United States Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to the U.S. national stockpile
.

Read the full story

Influenza Partnering

Tags: , , ,


The Influenza Partnering provides understanding and access to the influenza partnering deals and agreements entered into by the worlds leading healthcare companies Read the full story

cpbannerad300x150new2gif
rauconbadgejpg
e80banner300x150animgif
cabannerad300x150new4gif
rauconbadgejpg
a1banner300x150animgif